Lipoxins and other arachidonate derived mediators in bronchial asthma.
Chavis
C
C
Inserm U454, CHU de Montpellier, Hôpital Arnaud de Villeneuve, 34295 Montpellier, France. cchavis@montp.inserm.fr
Vachier
I
I
Godard
P
P
Bousquet
J
J
Chanez
P
P
D016718:Arachidonic Acid / Q000378:metabolism*; D001249:Asthma / Q000378:metabolism*; D000001:Calcimycin / Q000494:pharmacology; D018929:Cell Culture Techniques; D015777:Eicosanoids / Q000096:biosynthesis*; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D016676:Macrophages, Alveolar / Q000187:drug effects / Q000378:metabolism; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism
D015777:Eicosanoids; D005938:Glucocorticoids; D006893:Hydroxyeicosatetraenoic Acids; D007476:Ionophores; D016718:Arachidonic Acid; D000001:Calcimycin; C025984:15-hydroxy-5,8,11,13-eicosatetraenoic acid